Company news
Faron Pharmaceuticals Oy news in 2017
Faron Pharmaceuticals Oy's news releases, calls and decks from 2017, newest first.
INFORAAA trial receives recommendation from IDMC
December 19, 2017
Faron announces R&D Day in February 2018
December 14, 2017
Recruitment completed in Traumakine INTEREST Trial
December 11, 2017
Appointment of Chief Commercial Officer
December 1, 2017
Issue of Equity & PDMR Shareholding
October 11, 2017
Result of Placing & Subscription & Issue of Equity
October 9, 2017
Proposed Placing and Subscription
October 5, 2017
Traumakine Receives PIM Designation from MHRA
October 2, 2017
Directors Dealings
September 11, 2017
FDA advises Faron to proceed directly to BLA
September 4, 2017
Update on INTEREST Phase III Study from IDMC
August 4, 2017
Exercise of Warrants and Options
June 1, 2017
Exercise of Warrants
April 27, 2017
Director's dealings
April 26, 2017
Proposed Board Changes
April 19, 2017
Purchase of Shares
April 18, 2017
Final Results 2016
March 29, 2017
First Patient Recruited in Phase II RAAA Study
February 20, 2017
Faron update for 2017
February 9, 2017
Decks in 2017
- Shareholder Meeting (May 2017)
Shareholder meeting · 33 slides · May 16, 2017